In re Beech-Nut Nutrition Company Baby Food Litigation
Mital Patel & Danit Halberstein*
Why It Made the List
Food safety concerns remained a critical issue in 2024. In the wake of the 2021 congressional report finding that there are high levels of toxic heavy metals—including arsenic, lead, cadmium, and mercury—in baby foods being sold by some of the nation’s largest manufacturers, plaintiffs across the country have brought class actions against leading baby food manufacturers, alleging that their products contain dangerous levels of heavy metals.
The In re Beech-Nut Nutrition Company Baby Food Litigation decisions from 2024 and beyond out of the Northern District of New York and the Second Circuit addressed these challenges head-on. Plaintiffs alleged that Beech-Nut’s baby food products were misrepresented as safe, natural, and healthy, when in fact they contained or risked containing harmful heavy metals. What stemmed from this initial case were a series of decisions that are applicable beyond just baby food safety cases.
The March 2025 dismissal of the In Re Beech-Nut Nutrition Company Baby Food Litigation has set a new benchmark for consumer class actions based on economic harm, requiring plaintiffs to provide specific allegations of misrepresentation and quantifiable financial injury. The decision provides corporate defendants helpful guidance in mounting a defense challenging standing early and underscoring the need for careful marketing practices. Plaintiffs’ attorneys have taken note of these decisions and will likely attempt to craft complaints with these issues in mind. This ruling’s impact will resonate across consumer product industries beyond baby food, affecting how future class actions are structured and contested.
Decision and Background
In 2021, plaintiffs, purchasers of Beech-Nut baby food, brought a class action against Beech-Nut Nutrition Company alleging fraud, breaches of warranty, negligent misrepresentation, and violations of consumer protection statutes, based on the alleged presence of toxic heavy metals—such as arsenic, lead, cadmium, and mercury—in Beech-Nut’s baby food products.[1] Plaintiffs claimed Beech-Nut misled consumers by labeling its products with terms like “organic,” “natural,” “nothing artificial added,” and “real food for babies,” despite internally knowing those products contained or risked containing harmful contaminants. After plaintiffs filed a consolidated amended complaint, Beech-Nut moved to dismiss.[2]
Initially, the Northern District of New York dismissed the case, invoking the doctrine of primary jurisdiction and finding that FDA was better suited to determine the safety of heavy metals in baby food.[3] The court pointed to FDA’s “Closer to Zero” initiative as a sign that regulatory guidance was forthcoming, and that judicial intervention would be premature.[4] However, in January 2024, the U.S. Court of Appeals for the Second Circuit vacated, remanded, and reinstated the case.[5] The appellate court held that deferring to FDA would likely result in indefinite delay, as the agency had already missed key milestones for issuing limits on heavy metal content.[6] The appellate court concluded that plaintiffs’ claims could be adjudicated under existing state consumer protection and tort laws, and that courts need not wait for administrative rulemaking in order to address allegedly misleading marketing practices.[7]
Following remand, plaintiffs filed a Second Amended Consolidated Complaint, and in August 2024, Beech-Nut once again moved to dismiss under Rules 12(b)(1) and 12(b)(6), arguing plaintiffs lacked Article III standing and failed to state a claim.
In March 2025, the district court granted the motion to dismiss in full, holding that plaintiffs failed to plausibly allege a concrete and particularized injury-in-fact.[8] The court rejected both of plaintiffs’ asserted economic injury theories: 1) the benefit-of-the-bargain theory, which claimed the products were effectively worthless because they were unsafe; and 2) the price premium theory, under which plaintiffs argued they paid more for baby food marketed as safe and natural. The court noted that plaintiffs had not alleged that the products failed to provide nourishment or were actually harmful to their children, nor did they identify any specific misrepresentations about the presence of heavy metals on the packaging.[9]
The court also emphasized that vague marketing terms like “natural” or “real food” were not sufficient to support a fraud or misrepresentation claim absent allegations tying them directly to the alleged contamination.[10] Moreover, the court found that plaintiffs did not point to any comparable, cheaper baby food products free of heavy metals, undermining the price premium theory.[11] As a result, the court concluded that plaintiffs had not demonstrated a cognizable economic injury and therefore lacked standing under Article III.[12]
In late 2024, there was another baby food toxins decision. In In re Hain Celestial Heavy Metals Baby Food Litig., consumers filed a class action lawsuit against Hain Celestial, Inc., another baby food manufacturer.[13] The plaintiffs alleged that Hain Celestial deceptively marketed its baby food products as safe and of high quality while they contained dangerous levels of heavy metals such as lead, arsenic, cadmium, mercury, and perchlorate. The court found that the plaintiffs had adequately alleged standing to bring the lawsuit. The plaintiffs here claimed they suffered an injury-in-fact by paying a premium for Hain Celestial’s baby food products, believing them to be safe and of superior quality, which they would not have done had they known about the heavy metals. The court evaluated whether Hain Celestial’s labeling could be found materially misleading to a reasonable consumer. The district court granted in part and denied in part defendant’s motion to dismiss, finding that the plaintiffs plausibly alleged that some of Hain Celestial’s products exceeded recognized safe thresholds for arsenic in baby food and that this information would be material to reasonable consumers, allowing these claims to proceed to discovery. The district court found, however, the plaintiffs failed to plausibly allege that a reasonable consumer would be misled into believing that Hain Celestial’s baby food products were free from lead, cadmium, mercury, perchlorate, or other undesirable toxins and dismissed these claims because the plaintiffs did not provide specific benchmarks or thresholds indicating that the levels of these contaminants in Hain Celestial’s products were unsafe.
Impact of the Decision
At the heart of the plaintiffs’ case in In re Beech-Nut Nutrition Co. Baby Food Litigation were two economic harm theories common in consumer class actions: the benefit-of-the-bargain theory and the price premium theory. Plaintiffs claimed they had paid for safe and healthy baby food but received products containing toxic metals, or that they had paid a premium based on Beech-Nut’s marketing that suggested the products were safer than alternatives. However, the court rejected these arguments, ruling that the plaintiffs failed to demonstrate a concrete economic injury sufficient to establish Article III standing. Crucially, the plaintiffs did not allege that the baby food was unusable, that there were specific misrepresentations about the heavy metal content, or that any identifiable premium was paid directly because of deceptive marketing.
The ruling underscored a significant hurdle for future consumer class actions premised solely on economic harm without allegations of personal injury. Courts are demanding a higher level of specificity in claims of financial damage. This case suggests that simply asserting that consumers would not have purchased a product—or would have paid less—if they had known about a particular characteristic no longer suffices without clear, fact-specific allegations. Plaintiffs should now detail exactly how a company’s marketing led to an overpayment or created an economic harm that is both measurable and traceable to the defendant’s conduct.
This decision also illuminates a growing judicial split within New York’s federal courts. While the Northern District dismissed the claims against Beech-Nut, a similar case in the Southern District of New York against Nurture LLC, maker of Happy Baby Organics, allowed consumer claims to proceed.[14] In that case, the plaintiffs successfully alleged that specific marketing representations had induced them to pay more for what they believed were safer products. This inconsistency creates uncertainty for plaintiffs and defendants alike. Plaintiffs cannot rely on uniform treatment of economic injury claims, while defendants face varying litigation risks depending on jurisdiction. Moving forward, plaintiffs’ firms may be likely to engage in more strategic venue selection, targeting courts that have shown greater receptiveness to economic harm theories.
The Beech-Nut ruling also sends a cautionary signal to plaintiffs’ lawyers. Class actions built solely on generalized economic harm—without clear evidence of specific misrepresentations or quantifiable damages—will face steeper challenges. This is likely to deter speculative or marginal claims and shift plaintiffs’ firms toward cases where there is stronger evidence of either personal injury or concrete financial harm. In response, firms may pivot toward pursuing claims involving physical injuries linked to product defects or toxic exposure, where standing and damages are less ambiguous.
For corporate defendants, the decision offers a valuable blueprint for defense strategies. Companies will likely be more aggressive in challenging standing at the earliest stages of litigation, citing the Beech-Nut decision to argue for dismissal before costly discovery and trial phases begin. Additionally, businesses will review and refine their marketing language to minimize litigation risks, avoiding broad or potentially misleading claims about product safety or health benefits. Defense counsel will also continue to leverage favorable case law, like the Beech-Nut ruling, to argue against the sufficiency of plaintiffs’ economic harm allegations.
Beyond the baby food industry, this case has broader implications for consumer class actions across sectors including food and beverages, supplements, and personal care products. Many lawsuits in these areas rely on similar benefit-of-the-bargain and price premium arguments. The Beech-Nut decision signals to both plaintiffs and defendants that courts are increasingly unwilling to entertain economic injury claims lacking detailed, fact-specific support.
Ultimately, the Beech-Nut decision represents a significant tightening of the standards governing consumer class actions. It serves both as a warning to plaintiffs contemplating cases based on broad theories of economic harm and as a roadmap for defendants seeking early dismissal of such claims. As courts continue to grapple with the evolving landscape of consumer protection litigation, the Beech-Nut case will likely stand as an important decision in shaping how future claims are pleaded, defended, and adjudicated.
* Mital Patel and Danit Halberstein are associates at Foley Hoag LLP.
[1] In re Beech-Nut Nutrition Co. Baby Food Litig., No. 1:21-CV-133, 2025 U.S. Dist. LEXIS 49882, at *3 (N.D.N.Y. Mar. 19, 2025).
[2] In re Beech-Nut Nutrition Co. Baby Food Litig., 651 F. Supp. 3d 629 (N.D.N.Y. 2023).
[3] Id.
[4] Id. at 633.
[5] White v. Beech-Nut Nutrition Co., No. 23-220-cv, 2024 U.S. App. LEXIS 1145 (2d Cir. Jan. 18, 2024).
[6] Id. at *3–5.
[7] Id.
[8] In re Beech-Nut Nutrition Co. Baby Food Litig., No. 1:21-CV-133, 2025 U.S. Dist. LEXIS 49882 (N.D.N.Y. Mar. 19, 2025).
[9] Id.
[10] Id.
[11] Id.
[12] Id. at *16.
[13] In re Hain Celestial Heavy Metals Baby Food Litig., No. 21-cv-00678 (NRM) (AYS), 2024 U.S. Dist. LEXIS 233487 (E.D.N.Y. Dec. 27, 2024).
[14] In re Nurture Baby Food Litig., No. 1:21-cv-01217-MKV, 2025 U.S. Dist. LEXIS 56512 (S.D.N.Y. Mar. 26, 2025).
Top Food and Drug Cases, 2024
& Cases to Watch, 2025